Episode Description:
Regulation is designed to protect patients. Incentives are designed to drive behaviour. When they misalign, the whole system distorts.
What happens when 20 year approval cycles collide with startup timelines, when “wellness” blurs into medicine, and when payment models reward activity over outcomes?
Technology moves fast. Regulation and funding move slowly. The friction between the two is shaping what healthcare becomes next.
Key Topics:
- Regulation as trust infrastructure
- 20-year pathways from innovation to reimbursement
- The wellness vs medical grey zone
- Fee-for-service vs value-based care
- Quantity metrics vs quality outcomes
- Prevention and population health
- 30% healthcare waste
- Whether AI lowers costs or drives them up
Relevant Links and Resources:
Connect with us:
- Find all things Heidi at heidihealth.com
- Connect with Heidi on LinkedIn
- Connect with Dr Tom Kelly on LinkedIn
- Connect with Christina Farr:
- Check out Christina’s book 'The Storytellers Advantage'.
- Connect with Dr Hannah Allen on LinkedIn
- Connect with Dr Simon Kos on LinkedIn
Resources:
- Germany’s DiGA Fast-Track pathway (digital health reimbursement model): https://www.jmir.org/2024/1/e59013/
- FDA general guidance on medical devices & wellness products: https://www.fda.gov/medical-devices
- Official NHS Quality Of Outcomes Framework general practice data: https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/general-practice-data-hub/quality-outcomes-framework-qof
- New Zealand Deploys AI Scribe at a Population Level: https://www.healthcareitnews.com/news/anz/nz-deploy-ai-scribes-1000-emergency-clinicians
- McKinsey Report on Generative AI use and uptake: https://www.mckinsey.com/industries/healthcare/our-insights/generative-ai-in-healthcare-adoption-trends-and-whats-next
Trends in the shortfall of English NHS general practice doctors: https://www.bmj.com/content/390/bmj-2024-083978